
Core Viewpoint - OraSure Technologies, Inc. is set to hold its earnings conference call for the fourth quarter of 2024 on February 25, 2025, at 5 p.m. ET, to discuss financial results and business developments [1]. Company Overview - OraSure Technologies, Inc. focuses on transforming health through actionable insights and enhancing access to healthcare via innovative testing and sample management solutions [3]. - The company, along with its subsidiaries DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in developing, manufacturing, and distributing rapid diagnostic tests and sample collection devices [3]. - OraSure's products are sold globally to various sectors, including clinical laboratories, hospitals, physician's offices, public health organizations, research institutions, government agencies, and pharmaceutical companies [3].